The pertussis problem. (Q54406017)

29 May 2018

title

The pertussis problem. (English)

1 reference

29 May 2018

Stanley A Plotkin

1 reference

29 May 2018

language of work or name

English

0 references

publication date

20 December 2013

1 reference

29 May 2018

Clinical Infectious Diseases

published in

1 reference

29 May 2018

volume

1 reference

29 May 2018

issue

1 reference

29 May 2018

page(s)

830-833

1 reference

29 May 2018

Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussis

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT934

Sevenfold rise in likelihood of pertussis test requests in a stable set of Australian general practice encounters, 2000-2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT934

Pertussis re-emergence in the post-vaccination era

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT934

Bordetella pertussis strains with increased toxin production associated with pertussis resurgence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT934

Genome-wide gene expression analysis of Bordetella pertussis isolates associated with a resurgence in pertussis: elucidation of factors involved in the increased fitness of epidemic strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT934

First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT934

Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT934

Association between undervaccination with diphtheria, tetanus toxoids, and acellular pertussis (DTaP) vaccine and risk of pertussis infection in children 3 to 36 months of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT934

Nonmedical vaccine exemptions and pertussis in California, 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT934

Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT934

Effectiveness of pertussis vaccines for adolescents and adults: case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT934

Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT934

Waning immunity to pertussis following 5 doses of DTaP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT934

Diphtheria, tetanus, and pertussis vaccine. A comparison of the immune response and adverse reactions to conventional and acellular pertussis components

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT934

Immunity to the respiratory pathogen Bordetella pertussis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT934

Nonhuman primate model of pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT934

Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT934

Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT934

Waning protection after fifth dose of acellular pertussis vaccine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT934

Priming with whole-cell versus acellular pertussis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT934

Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT934

Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults--a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT934

The vaccine containing recombinant pertussis toxin induces early and long-lasting protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT934

Construction of Bordetella pertussis strains with enhanced production of genetically-inactivated Pertussis Toxin and Pertactin by unmarked allelic exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT934

Inflammasome activation by adenylate cyclase toxin directs Th17 responses and protection against Bordetella pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT934

Development of improved vaccines against whooping cough: current status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT934

Bordetella pertussis iron regulated proteins as potential vaccine components

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT934

Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT934

Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT934

Oligosaccharide conjugates of Bordetella pertussis and bronchiseptica induce bactericidal antibodies, an addition to pertussis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT934

The protective role of maternally derived antibodies against Bordetella pertussis in young infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT934

Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: a decision analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT934

Duration of immunity against pertussis after natural infection or vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT934

21 January 2018

Identifiers

DOI

10.1093/CID/CIT934

1 reference

29 May 2018

1 reference

29 May 2018